At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, ...

The FDA approved a new safety warning for Depo-Provera alerting patients to a possible risk for a type of brain tumor called meningioma.

Recent studies how found evidence that Depo-Provera massively increases the risk of developing brain tumors even after women ...

If you’ve experienced serious side effects after using Depo-Provera, you are not alone. The birth control injection has been linked to a range of adverse health effects, including bone density loss, ...

WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

Evidence indicates that Depo-Provera can cause specific mutations in women's DNA. Given the availability of alternatives without this known risk, the continued use of the shot difficult to justify.” — ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

Pfizer site manufacturing heparin active pharmaceutical ingredient. Pfizer is a pharmaceutical biotechnology corporation. U.S. government regulators have approved a new brain tumor warning for ...